{"tid":2322698,"cid":5,"subCid":0,"title":"疫苗研發以往一般以年計，過程中往往都係失敗多於成功。","createTime":"2020-12-12T13:37:03.000Z","updateTime":"2020-12-12T14:30:13.000Z","uid":261647,"like":2,"dislike":1,"uniUserReply":4,"replies":[{"pid":"6615db6ca017b6eebd9c37dbfc4c9117be3c8b7e","tid":2322698,"uid":261647,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-12T13:37:03.000Z","msg":"<a href=\"https://www.facebook.com/FrontlineTechWorkersConcernGroup/posts/3787756047930767\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.facebook.com%2FFrontlineTechWorkersConcernGroup%2Fposts%2F3787756047930767&d=Lu%2FYWbP3Pl%2BxzjQ0by0jchs8Bcr99949gko4GmpRTno%3D&h=cdbd2475\" target=\"_blank\">https://www.facebook.com/FrontlineTechWorkersConcernGroup/posts/3787756047930767</a><br />\n<br />\n作者：前線科技人員<br />\n<br />\n疫苗研發以往一般以年計，而且同所有科研一樣，過程中往往都係失敗多於成功。<br />\n<br />\n就喺過去幾日，世界各地幾間研發武肺疫苗嘅藥廠已經遭遇唔同嘅挫折，包括：<br />\n<br />\n- 歐洲 Sanofi/GSK 所研發的疫苗對老年人效果不佳，預料需重新調整配方，上市日期推遲至不早於 2021 年尾<br />\n<br />\n- 日本 AnGes 預計上市日期推遲至 2022 年<br />\n<br />\n- 澳洲 CSL/University of Queensland 所研發的疫苗因為所用者所產生的抗體對 HIV 產生 false positive，計劃被中止<br />\n<br />\n所以任何疫苗未經 Phase 3 Trial，結果未有公信力的 Journal 做 peer review，基本上可以不理。<br />\n<br />\n目前為止（12/12/2020）已公佈 Phase 3 Trial 結果的疫苗只有以下三種：<br />\nPfizer-BioNTech<br />\nModerna<br />\nOxford-AstraZeneca"},{"pid":"69fa01fb88accd8d1592451e3d00ed911bbc80db","tid":2322698,"uid":70786,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-12-12T13:39:16.000Z","msg":"3期冇Sinovac但係林鄭入咗750萬劑<img src=\"/assets/faces/mouse/tea.gif\" class=\"hkgmoji\" />"},{"pid":"de00c22c6bc0b3e7baad9393edb1ddb6c6fff0a7","tid":2322698,"uid":53026,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-12T14:21:31.000Z","msg":"支那呢？"},{"pid":"4924ba078bf9ade5615a37bd94be8f2a81aec4e1","tid":2322698,"uid":86898,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-12T14:30:13.000Z","msg":"唔好講研發，淨係phase 3 臨床試驗都最少一年半載<br />\n<br />\n支那疫苗固然唔打得，其實連歐美疫苗都係唔可信"}]}